title: Workshop report: European workshop on ataxia-telangiectasia, Frankfurt, 2011.
abstract: Ataxia-telangiectasia (A-T) is a devastating human recessive disorder characterized by progressive cerebellar ataxia, immunodeficiency, chromosomal instability, and cancer susceptibility. The European Workshop on Ataxia-Telangiectasia 2011 in Frankfurt focused on status quo of patient care and future clinical research directions. In Europe, approximately 600 patients are registered and many national websites have been established. During the meeting, guidelines of patient care were discussed and all participants agreed to build up an European A-T research network in near future to bring basic research and new therapies into clinical applications.
authors: Children's Hospital, Department of Allergy, Pneumology and Cystic Fibrosis, Goethe-University, Frankfurt am Main, Germany.
authors: Stefan
authors: S
authors: Zielen
authors: Ralf
authors: R
authors: Schubert
mesh_terms: D001260:Ataxia Telangiectasia / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D002986:Clinical Trials as Topic; D005060:Europe; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use
chemical_list: D007136:Immunoglobulins